Department of Life Sciences, Imperial College London, London, United Kingdom.
Department of Infectious Disease, Imperial College London, London, United Kingdom.
J Innate Immun. 2022;14(2):69-88. doi: 10.1159/000516956. Epub 2021 Oct 14.
Bacteria possess the ability to evolve varied and ingenious strategies to outwit the host immune system, instigating an evolutionary arms race. Proteases are amongst the many weapons employed by bacteria, which specifically cleave and neutralize key signalling molecules required for a coordinated immune response. In this article, we focus on a family of S8 subtilisin-like serine proteases expressed as cell-envelope proteases (CEPs) by group A and group B streptococci. Two of these proteases known as Streptococcus pyogenes CEP (SpyCEP) and C5a peptidase cleave the chemokine CXCL8 and the complement fragment C5a, respectively. Both CXCL8 and C5a are potent neutrophil-recruiting chemokines, and by neutralizing their activity, streptococci evade a key defence mechanism of innate immunity. We review the mechanisms by which CXCL8 and C5a recruit neutrophils and the characterization of SpyCEP and C5a peptidase, including both in vitro and in vivo studies. Recently described structural insights into the function of this CEP family are also discussed. We conclude by examining the progress of prototypic vaccines incorporating SpyCEP and C5a peptidase in their preparation. Since streptococci-producing SpyCEP and C5a peptidase are responsible for a considerable global disease burden, targeting these proteases by vaccination strategies or by small-molecule antagonists should provide protection from and promote the resolution of streptococcal infections.
细菌具有进化出多样化和巧妙策略的能力,以智胜宿主免疫系统,引发进化军备竞赛。蛋白酶是细菌使用的众多武器之一,它专门切割和中和协调免疫反应所需的关键信号分子。在本文中,我们专注于 A 组和 B 组链球菌表达的 S8 枯草杆菌蛋白酶样丝氨酸蛋白酶家族。其中两种蛋白酶,即化脓性链球菌 CEP(SpyCEP)和 C5a 肽酶,分别切割趋化因子 CXCL8 和补体片段 C5a。CXCL8 和 C5a 都是强效中性粒细胞募集趋化因子,通过中和它们的活性,链球菌逃避了先天免疫的关键防御机制。我们回顾了 CXCL8 和 C5a 招募中性粒细胞的机制以及 SpyCEP 和 C5a 肽酶的特性,包括体外和体内研究。还讨论了最近描述的该 CEP 家族功能的结构见解。最后,我们检查了包含 SpyCEP 和 C5a 肽酶的原型疫苗在其制备中的进展。由于产生 SpyCEP 和 C5a 肽酶的链球菌是造成相当大的全球疾病负担的原因,因此通过疫苗接种策略或小分子拮抗剂靶向这些蛋白酶应该可以提供针对链球菌感染的保护并促进其解决。